BlossomHill Therapeutics, Inc. (BLSM)

NASDAQ · Pharmaceuticals & Biotech · Pharmaceutical Preparations

Price

$22.34

Day

-11.52%

Market cap

$710.07M

Close 2026-09-23.

Insider trades

Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.

• GORDON CARL L (Director) bought 625,000 shares at $16.00 on 2026-08-10
• ORBIMED ADVISORS LLC (Director) bought 625,000 shares at $16.00 on 2026-08-10
• Liptak Vincent Paul (General Counsel) bought 2,200 shares at $16.00 on 2026-08-10
• Keyes Jason A (Chief Financial Officer) bought 700 shares at $16.00 on 2026-08-10
• Schmid John P. (Director) bought 6,000 shares at $16.00 on 2026-08-10
• Chen Bihua (Director,TenPercentOwner) bought 312,500 shares at $16.00 on 2026-08-10

Recent filings

• 8-K — 2026-09-18
• 10-Q — 2026-09-18
• 8-K — 2026-09-15
• SCHEDULE 13D — 2026-08-18
• SCHEDULE 13G — 2026-08-17
• SCHEDULE 13G — 2026-08-14
• SCHEDULE 13D — 2026-08-13
• 4 — 2026-08-12
• 4 — 2026-08-12
• 4 — 2026-08-10